Ra Pharmaceuticals, Inc. Insider Trading for February 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ra Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Ra Pharmaceuticals, Inc. for February 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 05 2019 | RARX | Ra Pharmaceuticals ... | King John C | Chief Commercial Of ... | Option Exercise | A | 21.00 | 107,000 | 2,247,000 | 107,000 | |
| Feb 05 2019 | RARX | Ra Pharmaceuticals ... | Lubner David Charles | Executive V.P. & CF ... | Option Exercise | M | 0.00 | 10,417 | 0 | 20,833 | |
| Feb 05 2019 | RARX | Ra Pharmaceuticals ... | Lubner David Charles | Executive V.P. & CF ... | Option Exercise | A | 21.00 | 133,000 | 2,793,000 | 133,000 | |
| Feb 05 2019 | RARX | Ra Pharmaceuticals ... | Lubner David Charles | Executive V.P. & CF ... | Payment of Exercise | F | 21.00 | 3,291 | 69,111 | 7,126 | 10.4 K to 7.1 K (-31.59 %) |
| Feb 05 2019 | RARX | Ra Pharmaceuticals ... | Lubner David Charles | Executive V.P. & CF ... | Buy | M | 0.00 | 10,417 | 0 | 10,417 | 0 to 10.4 K |
| Feb 05 2019 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Option Exercise | M | 0.00 | 9,167 | 0 | 18,333 | |
| Feb 05 2019 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Option Exercise | A | 21.00 | 107,000 | 2,247,000 | 107,000 | |
| Feb 05 2019 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Payment of Exercise | F | 21.00 | 2,933 | 61,593 | 6,234 | 9.2 K to 6.2 K (-32.00 %) |
| Feb 05 2019 | RARX | Ra Pharmaceuticals ... | Read Simon | Chief Scientific Of ... | Buy | M | 0.00 | 9,167 | 0 | 9,167 | 0 to 9.2 K |
| Feb 05 2019 | RARX | Ra Pharmaceuticals ... | Farzaneh-Far Ramin | Chief Medical Offic ... | Option Exercise | M | 0.00 | 10,417 | 0 | 20,833 | |
| Feb 05 2019 | RARX | Ra Pharmaceuticals ... | Farzaneh-Far Ramin | Chief Medical Offic ... | Option Exercise | A | 21.00 | 133,000 | 2,793,000 | 133,000 | |
| Feb 05 2019 | RARX | Ra Pharmaceuticals ... | Farzaneh-Far Ramin | Chief Medical Offic ... | Payment of Exercise | F | 21.00 | 3,285 | 68,985 | 7,132 | 10.4 K to 7.1 K (-31.53 %) |
| Feb 05 2019 | RARX | Ra Pharmaceuticals ... | Farzaneh-Far Ramin | Chief Medical Offic ... | Buy | M | 0.00 | 10,417 | 0 | 10,417 | 0 to 10.4 K |
| Feb 05 2019 | RARX | Ra Pharmaceuticals ... | Treco Douglas A | President and CEO | Option Exercise | M | 0.00 | 20,834 | 0 | 41,666 | |
| Feb 05 2019 | RARX | Ra Pharmaceuticals ... | Treco Douglas A | President and CEO | Option Exercise | A | 21.00 | 311,000 | 6,531,000 | 311,000 | |
| Feb 05 2019 | RARX | Ra Pharmaceuticals ... | Treco Douglas A | President and CEO | Payment of Exercise | F | 21.00 | 6,327 | 132,867 | 218,799 | 225.1 K to 218.8 K (-2.81 %) |
| Feb 05 2019 | RARX | Ra Pharmaceuticals ... | Treco Douglas A | President and CEO | Buy | M | 0.00 | 20,834 | 0 | 225,126 | 204.3 K to 225.1 K (+10.20 %) |